Furthermore, IPA supplementation in obese mice showed that it could effectively alleviate obesity and chronic inflammation, and the improvement effect may be related to the activation of AhR/IL-22 pathway to enhance intestinal barrier function. Here, IL22 is linked to obesity due to melanocortin 4 receptor deficiency.